Bifogade filer
PDF
Kurs
+3,81%
Kurs
+3,81%
Open
174,60
High
180,00
Low
161,70
Close
176,90
Kursutveckling under dagen för detta pressmeddelande
(SEK).
Likviditet
156 MSEK
Likviditet
156 MSEK
Rel. mcap
0,55%
Antal aktier
890 058
Likviditet under dagen för detta pressmeddelande
Kalender
| Tid* | ||
| 2026-01-29 | 08:00 | Bokslutskommuniké 2025 |
| 2025-10-23 | 08:00 | Kvartalsrapport 2025-Q3 |
| 2025-07-16 | 08:00 | Kvartalsrapport 2025-Q2 |
| 2025-04-29 | N/A | Årsstämma |
| 2025-04-16 | 08:00 | Kvartalsrapport 2025-Q1 |
| 2025-01-30 | 08:00 | Bokslutskommuniké 2024 |
| 2024-10-24 | - | Kvartalsrapport 2024-Q3 |
| 2024-07-17 | - | Kvartalsrapport 2024-Q2 |
| 2024-04-26 | - | X-dag ordinarie utdelning VITR 1.00 SEK |
| 2024-04-25 | - | Årsstämma |
| 2024-04-18 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-02 | - | Bokslutskommuniké 2023 |
| 2023-10-27 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-14 | - | Kvartalsrapport 2023-Q2 |
| 2023-04-28 | - | X-dag ordinarie utdelning VITR 0.85 SEK |
| 2023-04-27 | - | Årsstämma |
| 2023-04-21 | - | Kvartalsrapport 2023-Q1 |
| 2023-03-24 | - | X-dag bonusutdelning VITR 7 |
| 2023-02-02 | - | Bokslutskommuniké 2022 |
| 2022-10-27 | - | Kvartalsrapport 2022-Q3 |
| 2022-07-15 | - | Kvartalsrapport 2022-Q2 |
| 2022-04-28 | - | X-dag ordinarie utdelning VITR 0.80 SEK |
| 2022-04-27 | - | Årsstämma |
| 2022-04-22 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-16 | - | Bokslutskommuniké 2021 |
| 2021-10-29 | - | Kvartalsrapport 2021-Q3 |
| 2021-10-20 | - | Extra Bolagsstämma 2021 |
| 2021-07-15 | - | Kvartalsrapport 2021-Q2 |
| 2021-04-29 | - | X-dag ordinarie utdelning VITR 0.80 SEK |
| 2021-04-28 | - | Årsstämma |
| 2021-04-22 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-10 | - | Bokslutskommuniké 2020 |
| 2020-11-06 | - | Kvartalsrapport 2020-Q3 |
| 2020-07-13 | - | Kvartalsrapport 2020-Q2 |
| 2020-06-16 | - | X-dag ordinarie utdelning VITR 0.00 SEK |
| 2020-06-15 | - | Årsstämma |
| 2020-04-23 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-06 | - | Bokslutskommuniké 2019 |
| 2019-11-06 | - | Kvartalsrapport 2019-Q3 |
| 2019-07-12 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-03 | - | X-dag ordinarie utdelning VITR 0.85 SEK |
| 2019-05-02 | - | Årsstämma |
| 2019-04-23 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-08 | - | Bokslutskommuniké 2018 |
| 2018-11-06 | - | Kvartalsrapport 2018-Q3 |
| 2018-07-13 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-17 | - | Split VITR 1:5 |
| 2018-04-27 | - | X-dag ordinarie utdelning VITR 3.70 SEK |
| 2018-04-26 | - | Årsstämma |
| 2018-04-24 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-08 | - | Bokslutskommuniké 2017 |
| 2017-11-02 | - | Kvartalsrapport 2017-Q3 |
| 2017-07-14 | - | Kvartalsrapport 2017-Q2 |
| 2017-04-28 | - | X-dag ordinarie utdelning VITR 2.60 SEK |
| 2017-04-27 | - | Årsstämma |
| 2017-04-25 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-09 | - | Bokslutskommuniké 2016 |
| 2016-11-03 | - | Kvartalsrapport 2016-Q3 |
| 2016-09-20 | - | Kapitalmarknadsdag 2016 |
| 2016-07-15 | - | Kvartalsrapport 2016-Q2 |
| 2016-04-29 | - | X-dag ordinarie utdelning VITR 2.40 SEK |
| 2016-04-28 | - | Årsstämma |
| 2016-04-26 | - | Kvartalsrapport 2016-Q1 |
| 2016-02-05 | - | Bokslutskommuniké 2015 |
| 2015-11-05 | - | Kvartalsrapport 2015-Q3 |
| 2015-07-14 | - | Kvartalsrapport 2015-Q2 |
| 2015-05-06 | - | X-dag ordinarie utdelning VITR 1.50 SEK |
| 2015-05-05 | - | Årsstämma |
| 2015-04-28 | - | Kvartalsrapport 2015-Q1 |
| 2015-02-06 | - | Bokslutskommuniké 2014 |
| 2014-11-06 | - | Kapitalmarknadsdag 2014 |
| 2014-11-06 | - | Kvartalsrapport 2014-Q3 |
| 2014-11-06 | - | Analytiker möte 2014 |
| 2014-07-11 | - | Kvartalsrapport 2014-Q2 |
| 2014-05-06 | - | X-dag ordinarie utdelning VITR 1.00 SEK |
| 2014-05-05 | - | Årsstämma |
| 2014-04-23 | - | Kvartalsrapport 2014-Q1 |
| 2014-02-06 | - | Bokslutskommuniké 2013 |
| 2013-11-11 | - | Kapitalmarknadsdag 2013 |
| 2013-11-07 | - | Kvartalsrapport 2013-Q3 |
| 2013-11-07 | - | Analytiker möte 2013 |
| 2013-07-12 | - | Kvartalsrapport 2013-Q2 |
| 2013-04-30 | - | X-dag ordinarie utdelning VITR 0.60 SEK |
| 2013-04-29 | - | Årsstämma |
| 2013-04-19 | - | Kvartalsrapport 2013-Q1 |
| 2013-03-13 | - | 15-7 2013 |
| 2013-02-07 | - | Bokslutskommuniké 2012 |
| 2012-11-01 | - | Kvartalsrapport 2012-Q3 |
| 2012-11-01 | - | Analytiker möte 2012 |
| 2012-09-24 | - | Extra Bolagsstämma 2012 |
| 2012-07-13 | - | Kvartalsrapport 2012-Q2 |
| 2012-04-20 | - | X-dag ordinarie utdelning VITR 0.60 SEK |
| 2012-04-19 | - | Årsstämma |
| 2012-04-19 | - | Kvartalsrapport 2012-Q1 |
| 2012-02-07 | - | Bokslutskommuniké 2011 |
| 2011-10-27 | - | Kvartalsrapport 2011-Q3 |
| 2011-07-14 | - | Kvartalsrapport 2011-Q2 |
| 2011-04-28 | - | X-dag ordinarie utdelning VITR 0.60 SEK |
| 2011-04-27 | - | Årsstämma |
| 2011-04-27 | - | Kvartalsrapport 2011-Q1 |
| 2011-02-09 | - | Bokslutskommuniké 2010 |
| 2010-11-02 | - | Kvartalsrapport 2010-Q3 |
| 2010-07-15 | - | Kvartalsrapport 2010-Q2 |
| 2010-04-27 | - | Kvartalsrapport 2010-Q1 |
| 2010-04-27 | - | X-dag ordinarie utdelning VITR 0.50 SEK |
| 2010-04-26 | - | Årsstämma |
| 2010-02-05 | - | Bokslutskommuniké 2009 |
| 2009-11-03 | - | Kvartalsrapport 2009-Q3 |
| 2009-07-15 | - | Kvartalsrapport 2009-Q2 |
| 2009-04-28 | - | X-dag ordinarie utdelning VITR 0.40 SEK |
| 2009-04-27 | - | Årsstämma |
| 2009-04-27 | - | Kvartalsrapport 2009-Q1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Large Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
2022-10-27 08:00:00
Third quarter
- Sales of SEK 798 (406) million, corresponding to an increase of 97% in SEK, whereof acquired growth 75% and currency effect 20%. Sales pro forma, adjusted for business related to Covid-19 tests, increased by 5% in local currencies.
- Consumables increased sales by 18% in SEK, Technologies decreased by 5% in SEK, and Genetic Services contributed sales of SEK 348 million.
- Including the acquisition, we have strong growth in all market regions. Americas 222%, EMEA 33%, Japan Pacific 88% and Asia 33% in local currencies.
- Organic growth in local currency, pro forma, adjusted for business related to Covid-19 tests in Americas was 7%, EMEA -8%, Japan Pacific 32% and Asia 10% in local currencies.
- Restructuring costs for Genetic Services of SEK 29 million, whereof SEK 7 million impacted EBITDA and SEK 22 million impacted the financial net.
- Operating income before depreciation and amortisation (EBITDA) was SEK 276 (162) million, corresponding to a margin of 34.5% (40.0%) (pro forma 33.9). EBITDA per share increased by 47%.
- Net income was SEK 108 (105) million, resulting in earnings per share of SEK 0.80 (0.89).
- Sales of SEK 2,379 (1,167) million, corresponding to an increase of 104% in SEK, whereof acquired growth 76% and currency effect 17%. Sales pro forma, adjusted for business related to Covid-19 tests, increased by 10% in local currencies.
- Consumables increased sales by 23% in SEK Technologies by 10% in SEK, and Genetic Services contributed sales of SEK 993 million.
- Including the acquisition, we have strong growth in all market regions. Americas 238%, EMEA 55%, Japan Pacific 60% and Asia 40% in local currencies.
- Organic growth in local currency, pro forma, adjusted for business related to Covid-19 tests in Americas was 12%, EMEA 3%, Japan Pacific 18% and Asia 16% in local currencies.
- Restructuring costs for Genetic Services of SEK 31 million, whereof SEK 9 million impacted EBITDA and SEK 22 million impacted the financial net.
- Operating income before depreciation and amortisation (EBITDA) was SEK 777 (460) million, corresponding to a margin of 32.6% (39.4%) (pro forma 33.7). EBITDA per share increased 39%.
- Net income was SEK 321 (310) million, resulting in earnings per share of SEK 2.36 (2.77).
Gothenburg, October 27, 2022
VITROLIFE AB (publ)
Thomas Axelsson, CEO
Contact persons:
Thomas Axelsson, CEO, phone: +46 31 721 80 01
Patrik Tolf, CFO, phone: +46 31 766 90 21
This information is information that Vitrolife AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 8.00 am CET on October 27, 2022.
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.